Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
598.05
+9.78 (+1.66%)
Official Closing Price
Updated: 7:00 PM EST, Dec 8, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,446,792
Open
589.00
Bid (Size)
597.00 (1)
Ask (Size)
605.00 (1)
Prev. Close
588.27
Today's Range
584.77 - 598.30
52wk Range
302.14 - 629.97
Shares Outstanding
N/A
Dividend Yield
0.76%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Are These Biotechs Ready To Launch?
Today 0:05 EST
Biotech stocks are still in the process of repairing the damage from recent months — and recent years. Indeed, as of a month ago, the SPDR Biotech Fund had been dead money for an unbelievable eight and...
Via
Talk Markets
Bernie Sanders To Take On Ozempic, Wegovy, Weight Loss Drugs: 'Could Be Helpful, But They're Not Going To Be Helpful If People Can't Afford Them'
December 08, 2023
A hearing from the Senate led by Bernie Sanders will look at diabetes and the rise of weight loss drugs.
Via
Benzinga
Performance
YTD
+63.85%
+63.85%
1 Month
-3.40%
-3.40%
3 Month
+1.98%
+1.98%
6 Month
+34.08%
+34.08%
1 Year
+60.86%
+60.86%
More News
Read More
Pharma Giant Eli Lilly's Shareholder Bonanza: Announces Hefty 15% Dividend Hike For Q1
December 08, 2023
Via
Benzinga
Could Eli Lilly Beat Novo Nordisk in the Billion-Dollar Weight Loss Market?
December 08, 2023
Via
The Motley Fool
Challenging the Magnificent 7: 3 Stocks on the Rise
December 08, 2023
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Pictures Of Lilly
December 07, 2023
Via
Talk Markets
Eli Lilly's Options Frenzy: What You Need to Know
December 06, 2023
Via
Benzinga
What the Options Market Tells Us About Eli Lilly
December 04, 2023
Via
Benzinga
Will There Be A Recession In 2024?
December 07, 2023
Via
Talk Markets
Topics
Economy
Exposures
Economy
Neuropsychiatric Disorders and Treatment Market Projected to Show Strong Growth: Astrazeneca, AviadoBio, Astellas Pharma
December 07, 2023
Via
SBWire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Better Large-Cap Growth Fund: Schwab U.S. Large-Cap Growth or Vanguard Growth Index Fund?
December 07, 2023
Via
The Motley Fool
Should You Buy Eli Lilly Stock Now or Wait for a Dip?
December 07, 2023
Via
The Motley Fool
Which Stock Is More Likely to Help You Retire as a Millionaire: AbbVie or Eli Lilly?
December 07, 2023
Via
The Motley Fool
1 Monster Dividend Stock Growth Investors Should Load Up On Right Now
December 04, 2023
Via
The Motley Fool
JNJ CEO Signals No Rush Into Weight-Loss Drug Realm, Emphasizes Different Priorities
December 06, 2023
Via
Benzinga
Jim Cramer Highlights 'Transformational' Impact Of Weight Loss Drugs Like Ozempic: Focus Now On 'Potential Winners' From The Same Narrative
December 04, 2023
Via
Benzinga
Roche, Pfizer Race To Find Next Ozempic As Pharma Giants Hustle To Join Obesity Treatment Market
December 04, 2023
Via
Benzinga
Roche Stock Rises On $3.1 Billion Deal For Obesity Drugmaker
December 04, 2023
Via
Investor's Business Daily
Ozempic vs. Mounjaro:: Battle of the bulge
December 04, 2023
Via
MarketBeat
Exposures
Product Safety
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.
December 04, 2023
Via
The Motley Fool
Doing Your Holiday Shopping? These Stocks Might Make Great Gifts
December 04, 2023
Via
MarketBeat
Topics
Bonds
Exposures
Debt Markets
FDA Grants Second Conditional Approval For Eli Lilly's Rare Blood Cancer Drug
December 04, 2023
Via
Benzinga
Exposures
Product Safety
Roche Joins Bandwagon To Challenge Novo Nordisk, Eli Lilly For Weight Loss Drugs
December 04, 2023
Via
Benzinga
3 No-Brainer Growth Stocks to Buy in December
December 03, 2023
Via
The Motley Fool
Pfizer Tumbles After Abandoning Weight-Loss Pill
December 02, 2023
Via
Talk Markets
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.